Imatinib oral solution has gained FDA approval for the treatment of some cancers, including certain forms of leukemia.

Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...

How do scientists develop new treatments for disease? With Gleevec, a remarkable cancer drug, the approach was to target the disease at the cellular and subcellular level. When people say Gleevec ...

News on Inhibikase's promising treatments for PAH and Parkinson's Disease, supported by FDA approval and substantial funding.

the absence of ERK phosphorylation might explain the lack of clinical effectiveness of imatinib in these tumors—which was unexpected owing to the high levels of the imatinib target KIT.

Imatinib (Imkeldi) is the first oral liquid TKI approved for multiple cancers, enhancing treatment accessibility and dosing precision. The drug is effective as a first-line treatment, especially ...

Both metformin and imatinib were shown to reduce tumor growth ... This indicates that metformin doesn't just target tumor cells but also influences the surrounding immune environment, providing ...

Imatinib Target Exploration Consortium Study B2225. J Clin Oncol 2005; 23: 866–73 CrossRef MEDLINE 3. Rutkowski P, van Glabbeke M, Rankin CJ, et al.: Imatinib mesylate in advanced ...